Drug class
Investigational antiviral; herpes simplex virus (HSV) helicase-primase inhibitor
Mechanism of action
Inhibits the HSV helicase-primase complex, preventing viral DNA unwinding and replication. This mechanism is distinct from nucleoside analogues such as acyclovir.
General use cases
- Investigational oral treatment studied for acyclovir-resistant or acyclovir-refractory HSV infection, including in immunocompromised adults; pritelivir should not be represented as an approved routine therapy.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
